RT Journal Article
SR Electronic
T1 A COVID-19 Risk Assessment for the US Labor Force
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.13.20063776
DO 10.1101/2020.04.13.20063776
A1 Maher, Samantha
A1 Hill, Alexandra E
A1 Britton, Peter
A1 Fenichel, Eli P.
A1 Daszak, Peter
A1 Zambrana-Torrelio, Carlos
A1 Bayham, Jude
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.13.20063776.abstract
AB The consequences of COVID-19 infection varies substantially based on individual social risk factors and predisposing health conditions. Understanding this variability may be critical for targeting COVID-19 control measures, resources and policies, including efforts to return people back to the workplace. We compiled individual level data from the National Health Information Survey and Quarterly Census of Earnings and Wages to estimate the number of at-risk workers for each US county and industry, accounting for both social and health risks. Nearly 80% of all workers have at least one health risk and 11% are over 60 with an additional health risk. We document important variation in the at-risk population across states, counties, and industries that could provide a strategic underpinning to a staged return to work.One Sentence Summary There is important variability in the proportion of the US workforce at risk for COVID-19 complications across regions, counties, and industries that should be considered when targeting control and relief policies, and a staged return to work.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for authors Maher, Daszak, and Zambrana-Torrelio from EcoHealth Alliance is provided by the The National Institute of Allergy and Infectious Diseases (NIH) and the US Agency for International Development (USAID).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data are publicly available